ZEUS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease chronic kidney disease and systemic inflammation
Brief description of study
ZEUS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation
Clinical Study Identifier: s22-00843
ClinicalTrials.gov Identifier: NCT05021835
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
